Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone

scientific article published on 3 November 2005

Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BONE.2005.09.014
P698PubMed publication ID16271523

P50authorMary L. BouxseinQ66753654
P2093author name stringOlivier Borel
Claus Christiansen
Pierre D Delmas
Patrick Garnero
Evelyne Gineyts
Helene Solberg
Francois Duboeuf
P433issue3
P921main subjectbiomechanicsQ193378
P304page(s)300-309
P577publication date2005-11-03
P1433published inBoneQ15755003
P1476titleExtracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone
P478volume38

Reverse relations

cites work (P2860)
Q895213616'-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor binding
Q36296930A direct role of collagen glycation in bone fracture
Q34004460Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales.
Q41078194Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study
Q57137591Assessing glycation-mediated changes in human cortical bone with Raman spectroscopy
Q36656424Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls
Q38088714Biomarkers of bone turnover in oncology: applications in diagnosis and treatment
Q37029210Biomechanical characteristics of bone in streptozotocin-induced diabetic rats: An in-vivo randomized controlled experimental study
Q41294180Bone cells and bone turnover in diabetes mellitus
Q39331184Bone disease in diabetes: another manifestation of microvascular disease?
Q35096771Bone fracture toughness and strength correlate with collagen cross-link maturity in a dose-controlled lathyrism mouse model.
Q35825346Bone fragility in type 2 diabetes mellitus
Q37056305Bone metabolism and fracture risk in type 2 diabetes mellitus
Q36927957Bone quality in diabetes
Q38149092Bone quality: the determinants of bone strength and fragility.
Q81230244Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies
Q38364893Bone's Material Constituents and their Contribution to Bone Strength in Health, Disease, and Treatment.
Q51536719Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized m
Q37598559Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus
Q46277861Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs
Q36373016Determinants of bone strength and quality in diabetes mellitus in humans
Q38195566Diabetes, collagen, and bone quality
Q51151757Early Alterations in Bone Characteristics of Type I Diabetic Rat Femur: A Fourier Transform Infrared (FT-IR) Imaging Study.
Q38384409Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease
Q42243867Effects of in utero pestivirus infection on bovine fetal bone geometry, biomechanical properties and composition
Q46295396Effects of preexisting microdamage, collagen cross-links, degree of mineralization, age, and architecture on compressive mechanical properties of elderly human vertebral trabecular bone
Q35170244Exercise prevents β-aminopropionitrile-induced morphological changes to type I collagen in murine bone
Q90253734Fatigue as the missing link between bone fragility and fracture
Q57455729Feasibility of Serum Pentosidine Level as a Potential Risk Factor for Osteoporotic Vertebral Compression Fracture
Q35245623Focal therapeutic irradiation induces an early transient increase in bone glycation.
Q85206790Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes
Q41778121Influence of cross-link structure, density and mechanical properties in the mesoscale deformation mechanisms of collagen fibrils
Q33582160Intermittent parathyroid hormone (PTH) promotes cementogenesis and alleviates the catabolic effects of mechanical strain in cementoblasts.
Q37426367Is bone quality associated with collagen age?
Q57040812Limited field radiation therapy results in decreased bone fracture toughness in a murine model
Q84563754Lower osteocalcin and osteopontin contents of the femoral head in hip fracture patients than osteoarthritis patients
Q30979077Microindentation for in vivo measurement of bone tissue mechanical properties in humans.
Q98733469Nanoscale mechanisms in age-related hip-fractures
Q38700889Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.
Q46839982Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures
Q36587647Osteocytes--martyrs for integrity of bone strength
Q35071764Prediction of local ultimate strain and toughness of trabecular bone tissue by Raman material composition analysis
Q37396848Protective effect of total and supplemental vitamin C intake on the risk of hip fracture--a 17-year follow-up from the Framingham Osteoporosis Study.
Q45988732Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia.
Q46282165Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture
Q37858842Review: The diabetic bone: a cellular and molecular perspective
Q83979831Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats
Q37119404Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis
Q36850919Severity of aortic calcification is positively associated with vertebral fracture in older men--a densitometry study in the STRAMBO cohort
Q37143938Short-term free-fall landing causes reduced bone size and bending energy in femora of growing rats
Q35963018Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men.
Q55261199Structural and Biomechanical Adaptations to Free-Fall Landing in Hindlimb Cortical Bone of Growing Female Rats.
Q45877009Sustained swimming increases the mineral content and osteocyte density of salmon vertebral bone
Q38430261The Role of Collagen Organization on the Properties of Bone
Q37404948The contribution of collagen crosslinks to bone strength
Q38956808The effect of hyperglycaemia on osseointegration: a review of animal models of diabetes mellitus and titanium implant placement
Q37101353The effect of the microscopic and nanoscale structure on bone fragility
Q84204308Thinking inside and outside the envelopes of bone: dedicated to PDD
Q34332995Tibia bone properties at different time course of ovariectomized rats
Q37251944Trabecular bone mechanical properties in patients with fragility fractures
Q37476854Translational aspects of bone quality--vertebral fractures, cortical shell, microdamage and glycation: a tribute to Pierre D. Delmas
Q37315955Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life
Q38048186Type 2 diabetes and bone
Q64230394Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties
Q46022308Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study.
Q39874552Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment
Q42822884Viscoelastic and biomechanical properties of osteochondral tissue constructs generated from graded polycaprolactone and beta-tricalcium phosphate composites

Search more.